Who is sponsoring NCT04189874?

NCT04189874 is sponsored by Giulio DiDiodato.

What drugs are being tested in NCT04189874?

Interventions in NCT04189874: Conventional Stool Testing, BioFire FilmArray Gastrointestinal Panel.

What condition does NCT04189874 study?

NCT04189874 studies Infectious Gastroenteritis.

Is NCT04189874 still recruiting?

NCT04189874 is currently completed. Last updated 17 March 2021.

Last reviewed 2021-03-17 · How we verify

NCT04189874

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Stool Testing With Molecular Assay to Minimize Contact Precautions

Completed NA Last updated 17 March 2021

What this trial tests

NA trial testing Conventional Stool Testing in Infectious Gastroenteritis in 156 participants. Completed in 12 February 2021.

Timeline

18 December 2019

Primary endpoint
31 December 2020

12 February 2021

Quick facts

Lead sponsor	Giulio DiDiodato
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	health services research
Enrollment	156
Start date	18 December 2019
Primary completion	31 December 2020
Estimated completion	12 February 2021
Sites	1 location across Canada

Drugs / interventions tested

Conventional Stool Testing
BioFire FilmArray Gastrointestinal Panel

Conditions studied

Infectious Gastroenteritis — all drugs for Infectious Gastroenteritis →

Sponsor

Giulio DiDiodato

Who can join

Adults 1 Month to 110, any sex, with Infectious Gastroenteritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the impact of infectious diseases molecular-based stool testing compared to conventional stool testing on reducing the need for contact precautions among hospitalized patients. Half of patients' stools will be tested with the molecular assay , while the other half will be tested with conventional testing.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Efficacy of BioFire FilmArray Gastrointestinal Panel (FGP) to Reduce Hospital Costs Associated With Contact Isolation: A Pragmatic Randomized Controlled Trial
DiDiodato G, Allan A, Bradbury N, Brown J, et al · · 2021 · DOI 10.21203/rs.3.rs-846035/v1

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04189874 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Giulio DiDiodato
Last refreshed: 17 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04189874.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing